279 related articles for article (PubMed ID: 18056460)
21. Rapamycin synergizes cisplatin sensitivity in basal-like breast cancer cells through up-regulation of p73.
Wong SW; Tiong KH; Kong WY; Yue YC; Chua CH; Lim JY; Lee CY; Quah SI; Fow C; Chung C; So I; Tan BS; Choo HL; Rosli R; Cheong SK; Leong CO
Breast Cancer Res Treat; 2011 Jul; 128(2):301-13. PubMed ID: 20686837
[TBL] [Abstract][Full Text] [Related]
22. Prediction of epigenetically regulated genes in breast cancer cell lines.
Loss LA; Sadanandam A; Durinck S; Nautiyal S; Flaucher D; Carlton VE; Moorhead M; Lu Y; Gray JW; Faham M; Spellman P; Parvin B
BMC Bioinformatics; 2010 Jun; 11():305. PubMed ID: 20525369
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of promoter hypomethylation and expression of p73 as a diagnostic and prognostic biomarker in Wilms' tumour.
Song D; Yue L; Wu G; Ma S; Yang H; Liu Q; Zhang D; Xia Z; Jia J; Wang J
J Clin Pathol; 2016 Jan; 69(1):12-8. PubMed ID: 26184366
[TBL] [Abstract][Full Text] [Related]
24. Differential regulation of p73 variants in response to cisplatin treatment in SH-SY5Y neuroblastoma cells.
Million K; Horvilleur E; Goldschneider D; Agina M; Raguénez G; Tournier F; Bénard J; Douc-Rasy S
Int J Oncol; 2006 Jul; 29(1):147-54. PubMed ID: 16773194
[TBL] [Abstract][Full Text] [Related]
25. P73 gene expression in ovarian cancer tissues and cell lines.
Chen CL; Ip SM; Cheng D; Wong LC; Ngan HY
Clin Cancer Res; 2000 Oct; 6(10):3910-5. PubMed ID: 11051237
[TBL] [Abstract][Full Text] [Related]
26. Epigenetic silencing of ASPP1 confers 5-FU resistance in clear cell renal cell carcinoma by preventing p53 activation.
Wang X; Cheng Y; Zhu Y; Li H; Ge W; Wu X; Zhao K; Yuan J; Li Z; Jiang S; Han Z; Jiang Q; Wu Q; Liu T; Zhang C; Yu M; Hu Y
Int J Cancer; 2017 Oct; 141(7):1422-1433. PubMed ID: 28656647
[TBL] [Abstract][Full Text] [Related]
27. Epigenetic silencing of TGFBI confers resistance to trastuzumab in human breast cancer.
Palomeras S; Diaz-Lagares Á; Viñas G; Setien F; Ferreira HJ; Oliveras G; Crujeiras AB; Hernández A; Lum DH; Welm AL; Esteller M; Puig T
Breast Cancer Res; 2019 Jul; 21(1):79. PubMed ID: 31277676
[TBL] [Abstract][Full Text] [Related]
28. P73 regulates cisplatin-induced apoptosis in ovarian cancer cells via a calcium/calpain-dependent mechanism.
Al-Bahlani S; Fraser M; Wong AY; Sayan BS; Bergeron R; Melino G; Tsang BK
Oncogene; 2011 Oct; 30(41):4219-30. PubMed ID: 21516125
[TBL] [Abstract][Full Text] [Related]
29. CpG island methylation profiling in human melanoma cell lines.
Tellez CS; Shen L; Estécio MR; Jelinek J; Gershenwald JE; Issa JP
Melanoma Res; 2009 Jun; 19(3):146-55. PubMed ID: 19441164
[TBL] [Abstract][Full Text] [Related]
30. Role of ERCC1 promoter hypermethylation in drug resistance to cisplatin in human gliomas.
Chen HY; Shao CJ; Chen FR; Kwan AL; Chen ZP
Int J Cancer; 2010 Apr; 126(8):1944-1954. PubMed ID: 19626585
[TBL] [Abstract][Full Text] [Related]
31. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
32. Loss of Expression of Reprimo, a p53-induced Cell Cycle Arrest Gene, Correlates with Invasive Stage of Tumor Progression and p73 Expression in Gastric Cancer.
Saavedra K; Valbuena J; Olivares W; Marchant MJ; Rodríguez A; Torres-Estay V; Carrasco-Avino G; Guzmán L; Aguayo F; Roa JC; Corvalán AH
PLoS One; 2015; 10(5):e0125834. PubMed ID: 25954972
[TBL] [Abstract][Full Text] [Related]
33. Epigenetic inhibition of nuclear receptor small heterodimer partner is associated with and regulates hepatocellular carcinoma growth.
He N; Park K; Zhang Y; Huang J; Lu S; Wang L
Gastroenterology; 2008 Mar; 134(3):793-802. PubMed ID: 18325392
[TBL] [Abstract][Full Text] [Related]
34. [Relationship between mRNA expression and promoter methylation status of p73 gene in peripheral blood among children with Wilms' tumor].
Song DJ; Yue LF; Zhang D; Yang HY; Fan YX; Yue M; Pei H; Wang JX
Zhongguo Dang Dai Er Ke Za Zhi; 2013 Aug; 15(8):638-43. PubMed ID: 23965876
[TBL] [Abstract][Full Text] [Related]
35. Different intracellular compartmentalization of TA and DeltaNp73 in non-small cell lung cancer.
Di Vinci A; Sessa F; Casciano I; Banelli B; Franzi F; Brigati C; Allemanni G; Russo P; Dominioni L; Romani M
Int J Oncol; 2009 Feb; 34(2):449-56. PubMed ID: 19148480
[TBL] [Abstract][Full Text] [Related]
36. Epigenetic silencing of miR-493 increases the resistance to cisplatin in lung cancer by targeting tongue cancer resistance-related protein 1(TCRP1).
Gu Y; Zhang Z; Yin J; Ye J; Song Y; Liu H; Xiong Y; Lu M; Zheng G; He Z
J Exp Clin Cancer Res; 2017 Aug; 36(1):114. PubMed ID: 28859669
[TBL] [Abstract][Full Text] [Related]
37. Aberrant promoter methylation of multiple genes throughout the clinico-pathologic spectrum of B-cell neoplasia.
Rossi D; Capello D; Gloghini A; Franceschetti S; Paulli M; Bhatia K; Saglio G; Vitolo U; Pileri SA; Esteller M; Carbone A; Gaidano G
Haematologica; 2004 Feb; 89(2):154-64. PubMed ID: 15003890
[TBL] [Abstract][Full Text] [Related]
38. Kinetic modeling-based detection of genetic signatures that provide chemoresistance via the E2F1-p73/DNp73-miR-205 network.
Vera J; Schmitz U; Lai X; Engelmann D; Khan FM; Wolkenhauer O; Pützer BM
Cancer Res; 2013 Jun; 73(12):3511-24. PubMed ID: 23447575
[TBL] [Abstract][Full Text] [Related]
39. CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2.
Pulukuri SM; Rao JS
Oncogene; 2006 Aug; 25(33):4559-72. PubMed ID: 16786000
[TBL] [Abstract][Full Text] [Related]
40. [Effect of p73 gene on chemosensitivity of human lung adenocarcinoma cells H1299].
He Y; Fan SZ; Jiang YG; Chen JM; Li ZP; Zhou P; Zhou YG
Ai Zheng; 2004 Jun; 23(6):645-9. PubMed ID: 15191663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
